Table 1

Demographic characteristics of patients with PIMS-TS

AuthorCity, countryPeriodNumberAgeGenderComorbidityRaceIMC kg/m2
Whittaker et al3London, UK23 March and 16 May589 years (IQR 5.7–14)43% boys7/58 comorbidities69% black or AsianN/R
Riphagen et al6London, UK10 days in mid-April84–14 years
(range)
5/8 boyNone6/8 Afro-Caribbean14–33
7/8 > 75th centile/weight
Verdoni et al7Bergamo, Italy18 February and 20 April107.5 years (SD 3–5)7/10 boysN/RN/RN/R
Belhadjer et al8France (12 hospitals) and Switzerland (one hospital)22 March–30 April3510 years (IQR 8.2–12.4)51% boysComorbidities 28% (asthma 8.55; lupus 3%)N/ROverweight 17%
Golfred-Cato et al13Multicentre US1 March–29 July5708 (IQR 4–12)55.4% boysComorbidities 8%40.5% Hispanic and 33.1% black non-hispanicObesity 25.6%
Cheung et al33New York, USA18 April and 5 May178 years (IQR 1.8–16)47% boysMost were previously healthy (mild asthma in 3)White 70%N/R
Kaushik et al38New York, USA23 April–23 May3310 years (IQR 6–13)61% boysComorbidities
48%
45% Hispanic/latino
39% black
Overweight 12%
Obesity (BMI >30 kg/m2) 6%
Ramcharan et al40UK10 April and 9 May158.8 (IQR 6.4–11.2)
93% were over 5 years
73% boys100% African/Afro-Caribbean (40%), South Asian, (40%) Mixed (13%) or other monority ethnic
Toubiana et al45Paris, France27 April and 11 May21 children with features of Kawasaki disease7.9 years (IQR 3.7–16.6)43% boysN/R57% sub-Saharan Africa/Caribbean islands76% had a BMI below the 97th centile
Pouletty et al46Paris, FranceSince April 20201610 (IQR 4.7–12.5)50% boysComorbidities
37%
N/ROverweight 25%
Capone et al47New York, USA17 April–13 May338.6 years (IQR 5.5–12.6)61% boysComorbidities 21%73% non-HispanicOverweight 6%
Obese 39%
Feldstein et al48Multicentre, USA15 March–20 May1868.3 years (IQR 3.3–12.5)62% boysComorbidities 27%31% Hispanic, 25% black non- HispanicObesity 29%
Dufort et al49New York City1 March–10 May950–5 years (31%)
6–12 years (42%)
13–20 years (27%)
54% boysComorbidities 64%40% Black
36% Hispanic
Obesity 29%
  • BMI, body mass index; N/R, not reported; PIMS-TS, paediatric inflammatory multisystem syndrome temporally associated with COVID-19.